CAS: 1070773-09-9
Ref: IN-DA01ENVM
| 2mg | 53.00 € | ||
| 5mg | 74.00 € | ||
| 10mg | 108.00 € | ||
| 25mg | 153.00 € | ||
| 50mg | 242.00 € | ||
| 100mg | 512.00 € | ||
| 250mg | 614.00 € |
Estimated delivery in United States, on Wednesday 8 Jan 2025
Ref: 4Z-R-161002
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 9 Jan 2025
Ref: 4Z-R-161001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 9 Jan 2025
RK33
CAS:1070773-09-9
"RK33 is a DDX3 inhibitor causing G1 arrest, apoptosis, and radiation sensitization in DDX3-overexpressing cells."
Formula:
C23H20N6O3
Purity:
97.55%
Color and Shape:
Solid
Molecular weight:
428.44
Ref: TM-T6970
| 2mg | 35.00 € | ||
| 5mg | 51.00 € | ||
| 10mg | 77.00 € | ||
| 25mg | 140.00 € | ||
| 50mg | 209.00 € | ||
| 100mg | 341.00 € | ||
| 1mL*10mM (DMSO) | 56.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
RK 33
Controlled ProductCAS:1070773-09-9
Applications RK 33 is an inhibitor of DDX3, an ATP-dependent RNA helicase (1). Aberrant regulation …
Formula:
C23H20N6O3
Color and Shape:
Neat
Molecular weight:
428.44
Ref: TR-R545500
| 25mg | 769.00 € | ||
| 100mg | 1,467.00 € | ||
| 2500µg | 161.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
RK-33
CAS:1070773-09-9
RK-33 is a novel drug that belongs to the class of purine nucleoside phosphonates. It …
Formula:
C23H20N6O3
Purity:
Min. 95%
Molecular weight:
428.44 g/mol
Ref: 3D-VSB77309
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 19 Feb 2025
